Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
In the face of daunting disparities in health care, the medical community can take small steps that make a difference, a Columbia orthopedic surgeon writes.